A detailed history of Walleye Capital LLC transactions in Incyte Corp stock. As of the latest transaction made, Walleye Capital LLC holds 2,900 shares of INCY stock, worth $202,739. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,900
Previous 4,200 30.95%
Holding current value
$202,739
Previous $254,000 24.8%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$57.33 - $68.61 $919,515 - $1.1 Million
-16,039 Reduced 98.84%
188 $12,000
Q2 2024

Aug 14, 2024

BUY
$51.18 - $63.75 $164,185 - $204,510
3,208 Added 24.64%
16,227 $983,000
Q1 2024

May 15, 2024

BUY
$56.55 - $66.59 $736,224 - $866,935
13,019 New
13,019 $741,000
Q3 2023

Nov 14, 2023

BUY
$57.77 - $65.93 $396,879 - $452,939
6,870 Added 19.99%
41,229 $2.38 Million
Q2 2023

Aug 14, 2023

BUY
$60.95 - $75.51 $2.09 Million - $2.59 Million
34,359 New
34,359 $2.14 Million
Q3 2022

Nov 14, 2022

SELL
$66.18 - $82.86 $994,222 - $1.24 Million
-15,023 Reduced 66.87%
7,442 $496,000
Q2 2022

Aug 08, 2022

BUY
$66.18 - $83.18 $1.49 Million - $1.87 Million
22,465 New
22,465 $1.71 Million
Q3 2021

Nov 15, 2021

SELL
$68.67 - $84.02 $221,804 - $271,384
-3,230 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$79.87 - $87.53 $42,331 - $46,390
-530 Reduced 14.1%
3,230 $272,000
Q1 2021

May 17, 2021

BUY
$76.02 - $100.5 $285,835 - $377,880
3,760 New
3,760 $306,000
Q1 2020

May 15, 2020

SELL
$63.18 - $85.97 $544,611 - $741,061
-8,620 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$73.04 - $95.72 $1.21 Million - $1.59 Million
-16,626 Reduced 65.86%
8,620 $753,000
Q3 2019

Nov 14, 2019

BUY
$72.82 - $86.52 $1.83 Million - $2.17 Million
25,136 Added 22850.91%
25,246 $1.87 Million
Q2 2019

Aug 14, 2019

SELL
$73.52 - $88.7 $167,993 - $202,679
-2,285 Reduced 95.41%
110 $9,000
Q1 2019

May 15, 2019

BUY
$63.56 - $88.17 $152,226 - $211,167
2,395 New
2,395 $206,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.